Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next few years ...

This page is now closed, but a summary of the match is available below, and you can click here for our full match report. Thanks for joining us at Al Jazeera Sport.

The expanded collaboration now allows Reddit to use Google’s Vertex AI, which enables users to build, deploy, and scale machine learning models and AI applications, the author notes. Easily ...

Nintendo showed off the Switch 2 today. The internet has a lot of thoughts about it, good and bad. Allow me to weigh in. After the Nintendo Direct livestream ended on Wednesday morning, I got to ...

This page is now closed but a summary of the football match is available below, and you can go here for our full match report. Thanks for joining us at Al Jazeera Sport.

Kevin Lynch is a London-born, Dublin-based writer and journalist. The author of Steve Jobs: A Biographic Portrait, Kevin is a regular feature writer for a number of tech sites and the former ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

The Dallas Mavericks traveled to face the red-hot Chicago Bulls on Saturday, as the Bulls were seeking their fifth straight win. While the record made the Mavericks appear the better team, Chicago ...